Contact Us

Scott Gottlieb: The Long-Term Consequences of Viral Infections

Thought Leader: Scott Gottlieb
February 6, 2026
Written by: Scott Gottlieb

In a compelling Washington Post op-ed, former FDA Commissioner Scott Gottlieb shares his personal experience with Hodgkin lymphoma linked to Epstein-Barr virus (EBV) — a virus that infects roughly 90% of the global population and is often dismissed as mild. While many infections appear routine, Gottlieb argues that the long-term consequences can be profound and, in some cases, life-altering.

Drawing on emerging scientific evidence, he explains how EBV has been linked not only to lymphoma but also to multiple sclerosis, lupus, and other autoimmune diseases. He also highlights the resurgence of measles in the United States, warning that its damage extends far beyond a temporary illness, including long-term immune suppression and neurological complications.

Gottlieb challenges the assumption that vaccine-preventable diseases are inconsequential and cautions that weakening federal vaccine research and regulatory support could stall critical advancements — including the development of vaccines that may prevent certain cancers and chronic diseases. His message is clear: viral infections are not always fleeting, and prevention remains one of medicine’s most powerful tools.

Read the full op-ed in The Washington Post.

Dr. Scott Gottlieb, former Commissioner of the U.S. Food and Drug Administration, is one of today’s most trusted voices in healthcare policy and pharmaceutical innovation. With deep experience at the highest levels of public health leadership, Dr. Gottlieb offers expert analysis on the evolving landscape of healthcare regulation, drug development, biopharma trends, and global market forces such as tariffs and supply chain disruption. A physician, policymaker, and thought leader, he regularly advises organizations navigating complex health and economic challenges. His insights are essential for anyone seeking clarity at the intersection of science, policy, and innovation. For speaking inquiries, contact WWSG.

Relevant posts

Subscribe to the WWSG newsletter.

Check Availability

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

0
Speaker List
Share My List